Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 151 - 200 out of 44,862

Document Document Title
WO/2014/025604
The present application relates to recombinant microorganisms comprising engineered biosynthetic pathways and methods of using said recombinant microorganisms to produce various beneficial metabolites. In various aspects of the invention...  
WO/2014/023992
The application relates to a Yersinia pseudotuberculosis cell, which comprises nucleic acid coding for expression of at least one Yersinia pestis Caf1 polypeptide or of at least one antigenic fragment of Yersinia pestis Caf1, more partic...  
WO/2014/025605
The present compositions and methods relate to variant Ascomycetes sp. fungal cells that are genetically-modified to reduce the production of peptaibols, especially when grown on substrates containing insoluble material.  
WO/2014/025020
Provided is a culture method for microalgae that cultures microalgae in a liquid containing at least a fermented liquor. Provided is a method for using microalgae that makes it possible to efficiently utilize organic compounds stored in ...  
WO/2014/020290
The present invention concerns strains of Sarcocystidae chosen from Toxoplasma spp or Neospora spp isolated from the natural environment of same and having an immunostimulating effect for the use of same in the prevention or treatment, i...  
WO/2014/020933
Provided is a fluorescent substance which is highly safe when administered to a living body and is derived from a nucleic acid. A material for testing for fluorescence is used, which comprises at least one biological substance selected f...  
WO/2014/021533
The present invention relates to a microorganism having an acetyl CoA biosynthesis pathway and a butyryl CoA biosynthesis pathway; the microorganism being a recombinant microorganism having an increased ability to produce butanol, wherei...  
WO/2014/021339
It is found that a monoclonal antibody capable of recognizing at least two amino acid residues among amino acid residues located at position-69, position-79, position-81 and position-102 in human midkine has excellent reactivity with hum...  
WO/2014/019634
The invention relates to a device (1) and a method for treating a porous filtration medium (37) having a receiving unit (2) consisting of a receiving part (5) and a base part (6), wherein the porous filtration medium (37) can be received...  
WO/2014/019271
Biomarkers for diabetes and usages thereof are provided. And the biomarkers are Akkermansia muciniphilacBacteroides intestinaliscBacteroides sp. 20_3cClostridium bolteaec Clostridium hathewayicClostridium ramosumcClostridium sp. HGF2cClo...  
WO/2014/020291
The present invention concerns a mutant strain of Neospora spp, in which the function of the protein NcMIC3 and/or the function of the protein NcMIC1 is suppressed, and the uses thereof in a pharmaceutical composition or in a vaccine com...  
WO/2014/020215
The invention relates to a method for large-scale production of mycelial inoculum of ascomycota. Large-scale production of ascomycota is of great commercial interest, in particular that of important species belonging to the Tuber, Terfez...  
WO/2014/020653
[Problem] To provide: a method for breeding a novel species by interspecies crossing among Pleurotus sp. varieties such as Pleurotus eryngii (DC. :Fr.) Quel, Pleurotus eryngii (DC. :Fr.) Quel. var. elaeoselini, Pleurotus eryngii (DC. :Fr...  
WO/2014/021508
The present invention relates to a high strain containing high lipid content. The novel strain of the present invention contains high lipid content, high fatty acid content, and in particular contains palmitic acid, and therefore, can be...  
WO/2014/022692
In some aspects, the invention provides methods of modulating yeast fermentation or growth by modulating the [GAR+] prion. In some embodiments, [GAR+] is induced by contacting yeast cells with a bacterium that produces a small molecule i...  
WO/2014/021205
The present invention addresses the problem of providing: a lactic acid bacterium which has at least one effect selected from a fatigue-improving effect, a blood flow-improving effect, a stool odor-improving effect and a growth-promoting...  
WO/2014/021733
The invention relates to the field of microbiology and biotechnology, particularly to lactobacillus strains which can be used in food and medical biotechnology. Proposed are the strains Lactobacillus crispatus 2029 (ВКМ B-2727D), Lact...  
WO/2014/019696
The present invention concerns a semi-solid transport medium for isolation and identification of Helicobacter pylori, which comprises, for one litre of medium: 6.5 to 7.2 g granulated agar, 9.5 to 10.5 g enzymatic digest of casein, 9 to ...  
WO/2014/016979
This microbial activity modulator, which contains a microbial activity modulating substance and a carrying medium, and this method of modulating microbe activity, which involves a step for dosing microbes with the microbial activity modu...  
WO/2014/017106
The present invention is based, in part, on the discovery of isolated nucleic acid molecules encoding mutant RAC polypeptides, or a fragments thereof, wherein the mutant RAC polypeptides comprise one or more substitutions of an amino aci...  
WO/2014/018433
A method of making a flowable, dried agglomerated nutrient medium is provided. The method comprises introducing a nutrient component comprising a powdered nutrient, and an agglomeration liquid, into an agglomerator comprising a flow-thro...  
WO/2014/018549
A specific naturally occurring or genetically modified bacterial strain can be introduced into the hair follicle of patients suffering from androgenetic alopecia as to reduce the bioavailable extracellular testosterone and hence reduce t...  
WO/2014/018902
The present disclosure identifies methods and compositions for modifying photoautotrophic organisms as hosts, such that the organisms efficiently convert carbon dioxide and light into pyruvate or acetyl-CoA, and in particular the use of ...  
WO/2014/017394
The present invention provides: a transformant and a gene-disrupted strain which grow better in a calcareous soil than common plants and can accumulate iron and zinc in a larger amount both in a calcareous soil and in a good soil; a gene...  
WO/2014/018757
Yeast cells having a reductive TCA pathway from pyruvate or phosphoenolpyruvate to succinate, and which include at least one exogenous gene overexpressing an enzyme in that pathway, further contain an exogenous transhydrogenase gene.  
WO/2014/015841
The present invention involves a new method using micro-algae for the high-efficiency production of astaxanthin, said method comprising steps including the heterotrophic culture of micro-algae, dilution, light-induced culture, harvesting...  
WO/2014/018902
The present disclosure identifies methods and compositions for modifying photoautotrophic organisms as hosts, such that the organisms efficiently convert carbon dioxide and light into pyruvate or acetyl-CoA, and in particular the use of ...  
WO/2014/017233
Provided is a microbe activity modulator which contains a microbial activity modulating substance and a carrying medium and which is present in a reaction tank in a biological wastewater treatment facility.  
WO/2014/016328
The present invention provides tools and methods for production of fatty acids and derivatives thereof using genetically modified micro-organisms. The tools and methods are of interest in the anaerobic production of fatty acids on an ind...  
WO/2014/017642
The present invention provides a biological wastewater treatment device which is provided with a signal substance production unit which produces a signal substance by means of signal substance-producing bacteria, and a treatment unit whi...  
WO/2014/017513
The present invention provides: a method for culturing a cell and/or a tissue, said method being characterized by culturing the cell and/or the tissue in a floated state using a culture medium composition, wherein amorphous structures ar...  
WO/2014/016300
The present invention relates to glucagon analogues and their medical use, for example in the treatment of hypoglycaemia. In particular, the present invention relates to stable glucagon analogues suitable for use in a liquid formulation.  
WO/2014/018596
The invention provides compositions and methods for engineering E. coli or other host production bacterial strains to produce fucosylated oligosaccharides, and the use thereof in the prevention or treatment of infection.  
WO/2014/015841
Disclosed in the present invention is a method for the culture of micro-algae for the production of astaxanthin. The method comprises steps of heterotrophic culture of micro-algae, dilution, light-induced culture, collection of algae cel...  
WO/2014/018450
Improved haa1 transcriptional regulatory proteins, polynucleotides encoding improved haa1 transcriptional regulatory proteins and vectors and cells thereof are provided, as well as methods for converting a cellulose-containing biomass fe...  
WO/2014/018602
The present invention provides a host microorganism with a deletion, disruption or mutation in one or more enzymes of a glycerol dissimilation pathway and a plasmid without an antibiotic resistance gene but carrying one or more genes enc...  
WO/2014/013330
The invention relates to a method for producing 2,3-butanediol using improved strains of Raoultella planticola, and to novel mutant strains obtained by random mutagenesis from the bacterial species Raoultella planticola CECT843, that can...  
WO/2014/013489
A plurality of isolated polynucleotide sequences encoding enzymes of the astaxanthin pathway is disclosed. The polynucleotides include: (i) a polynucleotide which encodes Phytoene dehydrogenase (crtI) and a first transcriptional regulato...  
WO/2014/012129
The invention relates to a method for producing a product using micro-organisms. According to the invention, micro-organisms which form a glycocalyx are breed, the micro-organisms are then gathered, then from the gathered micro-organisms...  
WO/2014/012172
There is provided an isolated E. coli strain deposited at the International Depositary Authority of Canada (IDAC) on June 20th 2013 and attributed accession number 200613-01. There is also provided methods of using this strain for preven...  
WO/2014/013489
A plurality of isolated polynucleotide sequences encoding enzymes of the astaxanthin pathway is disclosed. The polynucleotides include: (i) a polynucleotide which encodes Phytoene dehydrogenase (crtI) and a first transcriptional regulato...  
WO/2014/012129
The invention relates to a method for producing a product using micro-organisms. According to the invention, micro-organisms which form a glycocalyx are breed, the micro-organisms are then gathered, then from the gathered micro-organisms...  
WO/2014/014258
The present invention relates to Pleurotus eryngii var. ferulae. More particularly, the present invention relates to a novel Pleurotus eryngii var. ferulae strain line following a line of DDL01 (KACC93085P) which is obtained by selecting...  
WO/2014/015179
The invention provides novel carbohydrate esters, in particular disaccharide esters, and the methods of their preparation. These compounds find use as microbial media components for the induction of gene expression in microbial fermentat...  
WO/2014/013074
The present invention relates to a mutant microbial host cell which is deficient in the production of the AgsE protein or in the production of an homologous thereof if compared with a parent microbial host cell which has not been modifie...  
WO/2014/013073
The present invention relates to a mutant microbial host cell which has been modified, preferably in its genome, to result in a deficiency in the production of a polypeptide having α-amylase activity AmyC or an homologous thereof. It ha...  
WO/2014/015210
The present invention provides non-naturally occurring microorganisms that have been modified to produce isoprene from glycerol. The microorganisms include one of several glycerol dissimilation pathways and one of several isoprene produc...  
WO/2014/009330
The invention relates to an isolated strain of Lactobacillus crispatus, identified as IP174178 and deposited at the CNCM under number I-4646 or an isolated strain having the same characteristics as IP174178. The invention also relates to...  
WO/2014/009435
The present invention concerns a method for the preparation of 2,4- dihydroxybutyric acid from homoserine comprising a first step of conversion of the primary amino group of homoserine to a carbonyl group to obtain 2-oxo-4- hydroxybutyra...  
WO/2014/010685
Disclosed are: a preservative agent for use in the low-temperature preservation of a biological material, which comprises a compound represented by formula (I); a preservative solution for use in the low-temperature preservation of a bio...  

Matches 151 - 200 out of 44,862